CHDI is delighted to announce that our 16th Annual HD Therapeutics Conference will be a fully online, virtual experience to be held April 27-29, 2021. The conference program is currently being crafted and will cover all aspects of drug discovery and development for Huntington’s disease.
Sessions will include:
- HD Human Genetics: Modifiers & Mechanisms Towards Medicines
- Preclinical Stage HD Programs
- Candidate Biomarkers for Huntingtin-Lowering Programs
- Clinical Stage Interventional Programs
Please join us to learn more and make new connections in the pursuit of therapeutics for Huntington’s disease.
If you are planning to present a poster, the deadline to register and complete your virtual poster booth is APRIL 2.